Search
Close this search box.

Nestlé and Roche Launch Cancer Care Program for Employees in Accra

Accra: Nestlé Ghana has announced the launch of a comprehensive cancer care program for its employees and their dependents in partnership with Roche. The initiative, named the 'Nestlé and Roche Cancer Care Program,' aims to provide holistic cancer care and support, addressing key aspects of the treatment journey, including access to advanced treatments and educational resources. According to Ghana News Agency, the program will enhance cancer care services by focusing on education, early detection, diagnosis, and ongoing support for cancer patients and their families. Mr. Georgios Badaro, Managing Director of Nestlé Ghana Ltd, emphasized the company's commitment to the well-being of its employees, describing the initiative as a profound dedication to their health and support. The program is set to ensure a comprehensive approach to non-communicable diseases care, offering unwavering support to staff affected by cancer. Mr. Badaro highlighted Nestlé's aim to be a beacon of hope for employees and their familie s, urging staff to participate in the program's education and screening initiatives. Ms. Antionette Arkoh, Human Resource Director for Nestlé Central and West Africa Region, stated that the cancer care program is part of the broader NesCare initiative, which addresses major non-communicable diseases such as hypertension and diabetes. She noted the program's unique patient navigation approach, designed to streamline clinical care and reduce waiting times. Dr. Elvis Kuma Forson, a doctor for Nestlé Ghana, underscored the importance of early detection through regular screening, particularly for breast cancer. Dr. Forson encouraged the public to perform self-examinations and seek professional checks regularly. The World Health Organization reports that cancer remains a leading cause of death globally, with lung, prostate, colorectal, stomach, and liver cancers being the most prevalent in men, and breast, colorectal, lung, cervical, and thyroid cancers most common in women.